101 related articles for article (PubMed ID: 9500213)
1. Prostate, breast and gynecological cancer markers RAK with homology to HIV-1.
Rakowicz-Szulczynska EM; Jackson B; Snyder W
Cancer Lett; 1998 Feb; 124(2):213-23. PubMed ID: 9500213
[TBL] [Abstract][Full Text] [Related]
2. Relevance of the viral RAK alpha gene in diagnosis of malignant versus nonmalignant tumors of the ovary and uterus.
Rakowicz-Szulczynska EM
Clin Diagn Lab Immunol; 2000 May; 7(3):360-5. PubMed ID: 10799446
[TBL] [Abstract][Full Text] [Related]
3. Human immunodeficiency virus type 1-like DNA sequences and immunoreactive viral particles with unique association with breast cancer.
Rakowicz-Szulczynska EM; Jackson B; Szulczynska AM; Smith M
Clin Diagn Lab Immunol; 1998 Sep; 5(5):645-53. PubMed ID: 9729531
[TBL] [Abstract][Full Text] [Related]
4. New protein and PCR markers RAK for diagnosis, prognosis and surgery guidance for breast cancer.
Rakowicz-Szulczynska EM; Markowski M; Mackiewicz A; Karczewska A; Snyder W; McIntosh DG; Kapcinska M; Smith ML
Cancer Lett; 1997 Jan; 112(1):93-101. PubMed ID: 9029174
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical versus molecular detection of RAK antigens in breast cancer.
Kyriacou KC; Iacovou F; Adamou A; Hadjisavvas A; Rakowicz-Szulczynska EM
Exp Mol Pathol; 2000 Aug; 69(1):27-36. PubMed ID: 10891290
[TBL] [Abstract][Full Text] [Related]
6. Prostate stem cell antigen (PSCA) mRNA expression in peripheral blood in patients with benign prostatic hyperplasia and/or prostate cancer.
Fawzy MS; Mohamed RH; Elfayoumi AR
Med Oncol; 2015 Mar; 32(3):74. PubMed ID: 25698533
[TBL] [Abstract][Full Text] [Related]
7. Expression and copy number analysis of TRPS1, EIF3S3 and MYC genes in breast and prostate cancer.
Savinainen KJ; Linja MJ; Saramäki OR; Tammela TL; Chang GT; Brinkmann AO; Visakorpi T
Br J Cancer; 2004 Mar; 90(5):1041-6. PubMed ID: 14997205
[TBL] [Abstract][Full Text] [Related]
8. Comparison of mRNA, Protein, and Urinary Nucleic Acid Levels of S100A8 and S100A9 between Prostate Cancer and BPH.
Yun SJ; Yan C; Jeong P; Kang HW; Kim YH; Kim EA; Lee OJ; Kim WT; Moon SK; Kim IY; Choi YH; Kim WJ
Ann Surg Oncol; 2015 Jul; 22(7):2439-45. PubMed ID: 25348783
[TBL] [Abstract][Full Text] [Related]
9. Rak, a novel nuclear tyrosine kinase expressed in epithelial cells.
Cance WG; Craven RJ; Bergman M; Xu L; Alitalo K; Liu ET
Cell Growth Differ; 1994 Dec; 5(12):1347-55. PubMed ID: 7696183
[TBL] [Abstract][Full Text] [Related]
10. Giant syncytia and virus-like particles in ovarian carcinoma cells isolated from ascites fluid.
Rakowicz-Szulczynska EM; McIntosh DG; Smith ML
Clin Diagn Lab Immunol; 1999 Jan; 6(1):115-26. PubMed ID: 9874674
[TBL] [Abstract][Full Text] [Related]
11. The novel human MOST-1 (C8orf17) gene exhibits tissue specific expression, maps to chromosome 8q24.2, and is overexpressed/amplified in high grade cancers of the breast and prostate.
Tan JM; Tock EP; Chow VT
Mol Pathol; 2003 Apr; 56(2):109-15. PubMed ID: 12665628
[TBL] [Abstract][Full Text] [Related]
12. Altered methylation of multiple genes in carcinogenesis of the prostate.
Yamanaka M; Watanabe M; Yamada Y; Takagi A; Murata T; Takahashi H; Suzuki H; Ito H; Tsukino H; Katoh T; Sugimura Y; Shiraishi T
Int J Cancer; 2003 Sep; 106(3):382-7. PubMed ID: 12845678
[TBL] [Abstract][Full Text] [Related]
13. PSGR2, a novel G-protein coupled receptor, is overexpressed in human prostate cancer.
Weng J; Wang J; Hu X; Wang F; Ittmann M; Liu M
Int J Cancer; 2006 Mar; 118(6):1471-80. PubMed ID: 16206286
[TBL] [Abstract][Full Text] [Related]
14. Clinical evaluation of prostate cancer gene 3 score in diagnosis among Chinese men with prostate cancer and benign prostatic hyperplasia.
Huang J; Reilly KH; Zhang HZ; Wang HB
BMC Urol; 2015 Dec; 15():118. PubMed ID: 26628213
[TBL] [Abstract][Full Text] [Related]
15. DD3(PCA3) gene expression in cancer and prostatic hyperplasia.
Floriano-Sánchez E; Cárdenas-Rodríguez N; Castro-Marín M; Alvarez-Grave P; Lara-Padilla E
Clin Invest Med; 2009 Dec; 32(6):E258. PubMed ID: 20003831
[TBL] [Abstract][Full Text] [Related]
16. Gene expression profiles of lysophosphatidic acid-related molecules in the prostate: relevance to prostate cancer and benign hyperplasia.
Zeng Y; Kakehi Y; Nouh MA; Tsunemori H; Sugimoto M; Wu XX
Prostate; 2009 Feb; 69(3):283-92. PubMed ID: 19025891
[TBL] [Abstract][Full Text] [Related]
17. Frequent 14-3-3 sigma promoter methylation in benign and malignant prostate lesions.
Henrique R; Jerónimo C; Hoque MO; Carvalho AL; Oliveira J; Teixeira MR; Lopes C; Sidransky D
DNA Cell Biol; 2005 Apr; 24(4):264-9. PubMed ID: 15812243
[TBL] [Abstract][Full Text] [Related]
18. Klf4 transcription factor is expressed in the cytoplasm of prostate cancer cells.
Le Magnen C; Bubendorf L; Ruiz C; Zlobec I; Bachmann A; Heberer M; Spagnoli GC; Wyler S; Mengus C
Eur J Cancer; 2013 Mar; 49(4):955-63. PubMed ID: 23089465
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic evaluation of cancer antigens RAK .1. Cervical and ovarian cancer.
Rakowiczszulczynska E; Roszak A; Mackiewicz A; Markowska J; McIntosh D; Karczewska A; Godlewski D; Snyder W; Leary D; Smith M
Int J Oncol; 1996 Oct; 9(4):693-9. PubMed ID: 21541570
[TBL] [Abstract][Full Text] [Related]
20. Promoter hypermethylation of the 14-3-3 sigma, SYK and CAGE-1 genes is related to the various phenotypes of urinary bladder carcinomas and associated with progression of transitional cell carcinomas.
Kunze E; Wendt M; Schlott T
Int J Mol Med; 2006 Oct; 18(4):547-57. PubMed ID: 16964403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]